Marketplace Policies

What's in the marketplace

The Veyda Marketplace surfaces vetted supplements, wearables, body-composition tools, and other health-relevant products. Some are sold by Veyda directly; others are fulfilled by third-party vendors. The vendor of record is always indicated on the product listing.

Supplements disclaimer

Statements made about supplements have not been evaluated by the U.S. Food and Drug Administration. Supplements are not intended to diagnose, treat, cure, or prevent any disease. Speak with your physician before starting any supplement, especially if you are pregnant, nursing, or taking other medications.

Vetting standards

Veyda evaluates marketplace products against a published rubric covering ingredient quality, third-party testing, labeling accuracy, and supplier reputation. We do not list a product unless it meets that bar. The rubric is reviewed quarterly by our clinical team. [LEGAL REVIEW: link to public rubric once finalized.]

Returns and shipping

Returns for marketplace products follow each vendor's return policy, surfaced at the time of purchase. Veyda-fulfilled products follow the Refund Policy. We do not currently ship outside the United States.

Third-party links

Some marketplace listings link out to third-party vendors. Once you leave Veyda, that vendor's terms and privacy policy govern. Veyda is not responsible for the content, security, or fulfillment of third-party sites.

Affiliate compensation

Veyda may receive affiliate compensation for some marketplace purchases. This compensation never influences which products we list — eligibility is determined exclusively by our clinical vetting rubric.

---

Counsel review queue — California considerations

Not final policy text. The items below capture the California-specific regulatory considerations our counsel needs to address before we publish the production version of these Marketplace Policies. Source: internal product/engineering review, May 2026.

California Genetic Information Privacy Act (SB-980, Civ. Code §§ 56.18–56.186)

If/when the marketplace surfaces direct-to-consumer genetic testing products (e.g., Nucleus, Health-DNA, TruDiagnostics — all confirmed launch partners per the Veyda Membership Notion page):

• Express, separate consent required for collection and use of genetic data — distinct from general membership consent.
• Right to delete genetic data on request, with mandatory destruction of biological samples and electronic records.
• Express consent before sharing with research collaborators, third-party storage, marketing, or law enforcement (absent court order).
• Security incident notification within 60 days of discovery.
• Practical step: gate the marketplace genetic-product checkout behind an SB-980-compliant consent module before listing those products.

FTC affiliate disclosure (16 CFR Part 255)

• The current "Affiliate compensation" section is good — counsel should confirm phrasing is sufficient under FTC Endorsement Guides updated 2023.
• Each individual product listing that triggers affiliate revenue should also include a disclosure (not just policy-level).
• "Material connection" must be disclosed near the recommendation — usually just before/after the product card.

Compounded medications + GLP-1s + peptides

• DTC GLP-1s and compounded peptides have evolving FDA/DEA scrutiny. Confirm:
  • Compounding pharmacy partner is FDA-503A compliant.
  • Patient-specific prescription required (no general distribution).
  • GLP-1 supply chain (semaglutide shortage status as of FDA 2024 declaration).

CA Health & Safety Code disclosures

• Supplements: CA Prop 65 warnings may apply. Confirm with supplement vendors that their products carry required Prop 65 warnings (or are exempt).
• Herbal products: CA AB-2098 + ingredient-disclosure rules.

Cross-state shipping

• Confirm tax + shipping rules for each product category. Some health products (e.g., kratom, certain peptides) are restricted in specific states.
• CA-only labs gate at launch is documented in the checkout flow but should be referenced in this policy too.

Liability for third-party fulfillment

• The "Third-party links" section is fine for soft launch. Counsel should confirm Veyda's liability shield language is sufficient under CA UCL (Unfair Competition Law) — courts have sometimes held facilitators liable for third-party harm where the platform exerts control.
• Indemnification + insurance coverage from each third-party vendor needed.

Specific items to revise in this draft

• Add: SB-980 genetic-data consent subsection (placeholder for when genetic products list).
• Add: Per-listing affiliate disclosure mention.
• Add: Prop 65 acknowledgment for supplements.
• Add: CA-only labs shipping note.